Gene therapy for lung cancer

Eric M Toloza1

  • 1Department of Surgery, Duke Thoracic Oncology Program, Duke University Medical Center, Durham, NC 27710, USA. toloz001@mc.duke.edu

Insights

Molecular insights into lung cancer have advanced, leading to gene therapy strategies. These therapies target genetic defects in non-small cell lung cancer for potential treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Significant progress in understanding lung cancer molecular biology over 30 years.
  • Development of gene therapy techniques to address genetic abnormalities in cancer cells.

Purpose of the Study:

  • Review therapeutic implications of molecular alterations in non-small cell lung cancer (NSCLC).
  • Assess the current status of gene therapy for NSCLC.

Main Methods:

  • Literature review of molecular biology advancements in lung cancer.
  • Analysis of gene therapy approaches targeting oncogenes, tumor suppressors, and apoptosis genes.

Main Results:

  • Delineation of key molecular pathways driving NSCLC development.
  • Identification of specific genes amenable to therapeutic targeting.

Conclusions:

  • Molecular understanding provides a foundation for novel gene-based therapeutic strategies in NSCLC.
  • Gene therapy holds promise for treating NSCLC by correcting genetic dysfunctions.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...